VALN is Valneva SE (Healthcare) — a non-dividend-paying stock. Trading at $7.12. Market cap: $623M.
Stock snapshot
| Price | $7.12 |
| Market cap | $623M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About VALN
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Related non-dividend companies
Other non-dividend stocks investors research alongside VALN. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VALN's current stock price?
VALN (Valneva SE) is currently trading at $7.12.
Does VALN pay a dividend?
VALN (Valneva SE) does not currently pay a regular dividend.
Track VALN in DiviDrip
Add VALN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VALN and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.